Epigallocatechin gallate has antibacterial and antibiofilm activity in methicillin resistant and susceptible Staphylococcus aureus of different lineages in non-cytotoxic concentrations.
Carina KnidelMonalessa Fábia PereiraDivan Henrique Fernandes BarcelosDaniel Cláudio de Oliveira GomesMarco César Cunegundes GuimarãesRicardo Pinto SchuenckPublished in: Natural product research (2019)
Staphylococcus aureus is an opportunistic agent that can cause a variety of infections, both hospital and community-acquired. Epigallocatechin gallate (EGCG), a flavonoid present in the leaves of Camellia sinensis, has different biological activities, including antimicrobial potential. Here we evaluate the antibacterial and antibiofilm potential of EGCG in nine clinical strains of S. aureus with different genetic profile and antimicrobial susceptibilities. The minimum inhibitory concentrations (MIC) of EGCG ranged from 7.81 to 62.5 μg/mL, and bactericidal activity was observed at 4 times the MIC. Sub-inhibitory concentrations were able to inhibit biofilm production. Concentrations ≤62.5 μg/mL of EGCG were non-cytotoxic for murine macrophages. EGCG significantly reduced the mortality of infected Galleria mellonella larvae with the S. aureus, having shown relevant antibiofilm properties and efficacy in inhibiting the growth of different clinical isolates of S. aureus, thus being a promising substance for the treatment of infections caused by this agent.
Keyphrases
- staphylococcus aureus
- biofilm formation
- methicillin resistant staphylococcus aureus
- healthcare
- escherichia coli
- silver nanoparticles
- mental health
- signaling pathway
- cardiovascular events
- genome wide
- gene expression
- type diabetes
- cardiovascular disease
- risk factors
- dna methylation
- anti inflammatory
- essential oil
- zika virus
- emergency department
- adverse drug
- climate change
- cystic fibrosis
- smoking cessation